INTRODUCTION
Molecular imaging using endogenous molecules has generated a lot of interest because the methodology does not have the adverse effects of gadolinium (Gd) contrast agents and has clinical benefits in pediatric patients or patients with a contraindication for the use of an exogenous contrast agent. Chemical exchange saturation transfer (CEST) imaging has been introduced as a potentially useful technique that provides contrast by amplifying the signal from endogenous molecules. The CEST technique uses selective radiofrequency (RF) saturation of the "protons of interest" and obtains contrast from the signal change in the bulk water, where saturated protons are subsequently transferred and they cause decreased signals in the water. The use of the signal from large bulk water greatly amplifies the sensitivity and enables to detect a relatively small amount of molecules at a high spatial resolution. Among the different types of CEST imaging, amide proton transfer (APT) imaging is the most widely used technique. It provides information on cellular proteins and physicochemical properties of tissue by using abundant amide protons that resonate at 3.5 ppm downfield from the water resonance. In our present review, we focus on the basic mechanism underlying APT imaging, the current clinical uses of APT in brain glioma, and its potential future use in cases of stroke. We also critically Amide Proton Transfer Imaging in Clinics: Basic Concepts and Current and Future Use in Brain Tumors and Stroke 임상에서 사용 가능한 아미드 수소 이동 영상: 기본 원리와 뇌종양 및 뇌경색에서의 현재 그리고 미래의 이용 Amide proton transfer (APT) imaging is gaining attention as a relatively new in vivo molecular imaging technique that has higher sensitivity and spatial resolution than magnetic resonance spectroscopy imaging. APT imaging is a subset of the chemical exchange saturation transfer mechanism, which can offer unique image contrast by selectively saturating protons in target molecules that get exchanged with protons in bulk water. In this review, we describe the basic concepts of APT imaging, particularly with regard to the benefit in clinics from the current literature. Clinical applications of APT imaging are described from two perspectives: in the diagnosis and monitoring of the treatment response in brain glioma by reflecting endogenous mobile proteins and peptides, and in the potential for stroke imaging with respect to tissue acidity.
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THEORETICAL BACKGROUND OF APT IMAGING AND ISSUES REGARDING THE ORIGIN OF SIGNAL SOURCE

Theoretical Background of APT Imaging
APT imaging is a type of CEST imaging, in which off-resonance RF irradiation leads to magnetization of the "protons of interest, " and the signal is detected indirectly through the chemical exchange with bulk water protons. Amide protons (protons -of -interest) resonate 3.5 ppm downfield from the water resonance (which is 8.25 ppm, compared to 4.75 ppm for water) via a chemical shift in the nuclear magnetic resonance (NMR) spectrum. In hydrogen 1 ( 1 H) MR spectroscopy, the signal peak comes directly from the solute proton in the water pool. Since the abundance of metabolites is much less than that of water protons in tissue (in the concentration range of μM to mM) (1), the signal-to-noise ratio is low and a long scanning time is required for resolution. On the other hand, CEST indirectly reflects the solute proton via the signal of the abundant water pool. When a selective RF pulse is applied at 3.5 ppm, the proton attached to the amide bond becomes saturated. Subsequently, these saturated protons move to the neighboring water and exchange with the free water protons. A single transfer of saturation would be insufficient to cause any discernible effect on water pool (2), but prolonged irradiation causes a large amount of water protons to become saturated by the chemical exchange. Fig. 1 shows the CEST mechanism. The solute protons are saturated at their specific resonance frequency shown in 1 H NMR with a selective RF pulse.
The saturation effect is transferred to water (H 2 O, 4.75 ppm) at an exchange rate, and this effect becomes visible on the water signal. Due to this CEST effect on abundant water protons, labile protons of low-concentration solutes can be imaged indirectly.
Considering the effect of signal amplification of CEST compared to MR spectroscopy, there is nearly a ~700-fold sensitivity improvement in CEST of glutamate molecules (3) compared to conventional 1 H MR spectroscopy at physiological concentrations and temperatures. Fig. 2 shows the difference spectra at 3 ppm points on the where the ratio of the CEST difference spectrum to NMR glutamate resonance at 2.3 ppm is ~700. This analysis is applied to remove the direct water saturation (i.e., the spillover effect) (4-6) and broad macromolecular magnetization transfer contrast (MTC) from the off-resonance RF irradiation (7).
Issues Regarding the Origin of Signal Source in APT Imaging
The water longitudinal relaxation time (T1w) and water proton concentration can affect the APT signal (2, 7, 8) . With respect to (12, 13) . Here, the Z-spectrum reflects the RF saturation effects on water as a function of saturation frequency offset relative to water (14) . Since B0 inhomogeneity scales with field strength, it is particularly significant at higher magnetic fields than at lower magnetic fields. The irradiated RF field (B1) inhomogeneity can result in increased direct water saturation and insufficient saturation of the exchanging pool, which can then lead to inaccuracies in APT analysis. However, in the clinical MRI field strength, B0 inhomogeneity often results in more significant errors in APT analysis than B1 inhomogeneity does, if spatially uniform saturation is achieved (15) .
Correction of B0 inhomogeneity can be accomplished by field mapping using the gradient-echo sequence (16) or by identifying the water resonance frequency and shifting either the partial or whole range of Z-spectrum to align with the center frequency, which has been developed in the form of water saturation shift referencing (13) . Other correction methods include acquisition using the entire (12, (17) (18) (19) or partial (20) Z-spectrum or using multiple echoes (21) . for estimation of B0 inhomogeneity simultaneously with acquisition of Z-spectrum.
Specific Absorption Rate
In clinics, APT imaging sequence is required for MR image acquisitions with RF irradiation at multiple saturation frequencies using relatively weak and prolonged saturation RF pulses. Therefore, the first and foremost challenge for practical applications of APT in clinical MRI devices is to stay within the FDA-allowed specific absorption rate (SAR) with RF irradiation long enough to obtain the maximum saturation under a given RF duty cycle limit supporting the maximum lesion coverage and a clinically feasible scan time. The SAR can be reduced by using weaker or
shorter RF pulses at the cost of a smaller APT effect and/or by using parallel imaging in which the repetition time (TR) can be relatively increased by reducing the phase-encoding steps. This can result in a reduction of the average SAR, if the same saturation RF schemes are used with the same scan time. On the other hand, if TR is increased with a constant SAR limit, the APT effect can be increased by using a stronger saturation RF power in some B1 limited applications.
APT Imaging Pulse Sequence
Even though an APT sequence satisfies the minimum SAR requirement, it is not trivial to achieve a long duration of RF irradiation, as clinical scanners cannot generate RF irradiation with a high duty cycle, limiting the typical saturation RF length to 250-500 ms. Therefore, pulsed saturation approaches are commonly used in clinical MRI scanners, wherein a train of saturation RF pulses is used with crusher gradients. Alternatively, one or multiple short saturation RF pulses are inserted into the two-dimensional or three-dimensional (3D) gradient-echo (22, 23) , segmented echo-planar imaging (24, 25) , turbo spin-echo (19, 26, 27) or gradient-and spin-echo image readout (12, 18) . This leads to accumulation of the saturation effect for slowly exchanging species, e.g., amide protons, due to a relatively short imaging TR, which is much less than the relaxation time (T1) of tissue.
APT Imaging Data Processing
There are many confounding CEST effects that contribute to jksronline.org 
CLINICAL APPLICATIONS
Brain Tumor Imaging
In the interest of reflecting mobile protein contents and peptides, APT imaging has been applied to brain tumor imaging in both experimental and clinical studies. It has been used in diverse applications to evaluate brain tumors: characterizing a tumor and its differential diagnosis, tumor grading as an index for tumor proliferation, and treatment monitoring.
Tumor Extent
The first human experimental result for APT in a brain tumor was investigated to quantify the APT effect in a clinical MRI system (27) . can mimic glioblastoma, and a differential diagnosis between the two entities is important, as the mainstay of treatment for glioblastoma is maximal safe resection while PCNSL requires biopsy followed by chemotherapy. Eleven PCNSL patients were compared to 21 high grade glioma patients using APT imaging on 3T (50) . The PCNSLs showed lower maximum and more homogeneous APT signals and higher MTR asymmetry than high-grade glioma lesions. The author explains that the signal difference was related to the histological characteristics of PCNSL, which has a higher N/C ratio (i.e., less cytoplasm and more nuclei and membranes) compared to high-grade glioma.
Therapeutic Monitoring
Identifying an imaging biomarker that reflects the therapeutic response is clinically important to determine whether to discontinue the current treatment and/or to initiate other treatment options. The first experimental study of APT for therapeutic monitoring of glioblastoma was performed for quantitative assessment of the treatment response during chemotherapy (51) . One course of temozolomide (TMZ 80 mg/kg i.p. for three days) was applied to a mouse tumor model, and APT asymmetry was measured before and after treatment at a one-week interval. APT asymme- One study showed that the diagnostic performance of APT imaging was 0.98, applying the area-under-the-curve using a receiver operating characteristic analysis with a sensitivity of 85.0% and a specificity of 100% (52) . Another study showed the added value of APT imaging to conventional and perfusion MRI for posttreatment glioblastomas (53) . Adding APT imaging to conventional and perfusion MRI significantly improved the diagnostic performance: from 0.58-0.74 to 0.89-0.91. Moreover, the combination of contrast-enhanced T1 weighted imaging, perfusionweighted imaging (nCBV90), and APT imaging (90th percentile of the signal, APT90) resulted in greater diagnostic accuracy for differentiating treatment change from progression than did the combination of contrast-enhanced T1 and perfusion-weighted imaging only. These studies showed promising results which suggest that combining APT imaging with multiparametric MRI assessment will be beneficial for treating glioblastoma patients.
Metabolic spectra (a.u.) Where R1w is the spin-lattice relaxation rate of the bulk water and tsat is the saturation duration. From previous experimental studies on the ischemic tissue, we assume that the average tissue R1w is constant and the effect of the amide proton content (amide proton) and water content (H2O) for the MTR asymmetry curve is minimal at the amide frequency (28) . Therefore, the above APTR is translated to be greatly affected by k, where k = kbase
[OH] = kbase × 10 pH-pKw with the ionization constant, pK w . Thus, APTR can be a function of acid-base pH calibration. Therefore, in ischemic tissue, APT asymmetry decreases with decreasing pH (28, 56, 57) .
Potential Utility of APT Imaging in Stroke Patients
An animal model study using a 4. However, a large portion of the posterior temporal lobe also showed a symmetric, negative contrast, which hampered the interpretation in terms of tissue acidosis.
Both technical and practical considerations for the use of APT imaging in stroke patients need to be addressed. First, the effect of B0 field inhomogeneity and direct water saturation can obscure lesions in the vicinity of the cerebrospinal fluid space, including the cerebral convexity adjacent to the sulci, where an acute infarction typically occurs. Second, acute stroke patients need a fast imaging tool that is robust, which is limited by motion and noise in the currently available techniques. Third, CEST sensitivity is low according to pH changes in amide protons. Although the CEST effect is shown to be sensitive to changes in pH, the sensitivity of an amide proton was found to be lower than that of an amine proton, a faster-exchanging molecule in the physiologic range (i.e., pH 6.0-8.5) (3, 8, 38, 59) . Finally, the interpretation of APT imaging in the subacute phase is not straightforward, and several factors can significantly increase APT asymmetry (i.e., proteolysis and inflammation are likely to increase the amount of mobile proteins) (22) . This increase opposes the reduction in APT asymmetry caused by a reduced pH, thus limiting the interval window for APT imaging and interpretation in the subacute stage.
Future Considerations for Stroke Imaging
We may use the target labile protons of amine rather than amide in stroke imaging. For the amine proton, which has a peak centered around 3 ppm, the CEST effects appear to increase as pH decreases in the physiologic range (3, 8, 38, 60) .
At pH 7, amine CEST asymmetry is reduced due to the well- 
